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 The healthcare industry is experiencing a period of evolution and 
introspection. With Medicare and Medicaid expenses alone reaching $897.9 billion 
in 2015, providers are facing increased financial, governmental and public pressure 
to reduce costs, and at the same time deliver higher quality care. This study seeks to 
determine if there is a difference between the Disproportionate Share Hospital’s 
(DSH), which receive financial assistance due to their high proportions of indigent 
patients and facilities that fail to qualify for DSH funding. The ACA will significantly 
reduce the Disproportionate Share Hospital provision to cut costs by 2022. The 
impact of this provision is not fully understood and this study seeks to determine if 
DSH funding provides a tangible benefit for the facilities that receive this 
supplemental assistance. The data for this study was attained from the Centers for 
Medicare and Medicaid Services and Hospital Compare. Facilities were grouped 
based on whether or not they received DSH funding, and their measured quality, 
safety, efficiency and financial health was analyzed. Findings suggest that there is no 
statistically significant association between DSH funding and hospital quality, safety 
and efficiency. There was, however, a nominal improvement in day’s cash on hand 
and operating margin when comparing DSH to non-DSH facilities. The findings of 
this paper suggest that DSH funding should not be phased out, as its impact may go 
beyond the domain of patient care and affect a facility’s financial viability, which in 





Statement of Problem 
Introduction 
 
America’s hospitals are at a turning point, faced with increased pressure, 
both financially and publicly to bring higher quality care at a lower price. As our 
country moves to consolidate its spending, our legislators will look to the largest 
expenses to cut costs. One area that has been a target is healthcare, with Medicare 
and Medicaid expenses totaling $897.9 Billion in 2015 [1]. The Patient Protection 
and Affordable Care Act (PPACA) aims to cut health care costs in multiple ways. To 
put it simply the PPACA will try to cut costs by keeping the population healthier, and 
by treating illnesses with the most efficient and effective methods available. In 
theory, these practices will lead to lower costs with better outcomes, but as is often 
the case, theory and reality are rarely the same.  
 
 To cut costs the PPACA will move health care from a fee-for-service model, to 
a model based on pay-for-performance [2]. In addition to implementing new 
payment methodologies, the PPACA will cut costs by phasing out current subsidies 
for acute care facilities that serve an indigent population, and funding for graduate 
medical education [5,8]. The former of these two payment supplements is the focus 
of this paper. Disproportionate Share Hospitals (DSH) funds have historically been 
used to supplement hospitals that serve large low-income populations, due to the 
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greater cost of care associated with these patients. These patients often do not have 
access to the routine primary care that prevents manageable conditions from 
evolving in to chronic diseases with life threatening complications. In addition to not 
having access to adequate primary care, these populations often delay seeking 
treatment for chronic conditions until they become life threatening [3]. These 
factors, beyond the control of the facilities that treat them, have been shown to 
decrease a hospitals quality of care scores [2].  
 
 As value based purchasing and other quality driven incentives are 
implemented, hospitals will gradually be held more and more accountable for their 
performance. To support these cost saving measures, reimbursement 
methodologies will begin to penalize those facilities that fail to meet government 
established quality and safety metrics. In addition to bearing the losses of DSH and 
IME funds, these facilities will also bear the administrative burden of compiling and 
reporting the quality metrics that will be used to determine their reimbursement 
[4]. Not only will these metrics factor into a facilities reimbursement rates, these 
metrics have been shown to be susceptible to surveillance bias. Studies conducted 
on Patient Safety Indicator-12 (PSI-12), indicated a positive correlation between 
increased PSI-12 surveillance and PSI-12 reporting. This fear has also been linked to 
PSI-3, which measures pressure ulcers. This is problematic as PSI-12 and PSI-3 
factor into the PSI-90 composite safety indicator, which is part of the clinical process 






 Hospitals were not always centers of innovation that they represent today. 
Their origins lie in charitable organizations founded by wealthy public figures or 
religious organizations to help care for large indigent populations. As a testament to 
their charitable beginnings, in 1922 patient revenues accounted for on average 
65.2% of hospitals total revenue. By 1994 this figure reached 94% of  hospitals total 
revenue [5]. As the health care landscape continued to change, hospitals saw less of 
their revenue come from donations and an increase in revenue due to privately 
insured or government covered individuals. In response to this shift in revenue 
source, hospitals began taking more responsibility for those who could not afford to 
pay for the treatment they required. Since hospitals that serve large low-income 
populations are often not able to “cost shift”, which is the process of charging 
private payers more to make up for inadequate government payments [11], 
legislators passed The Omnibus Budget Reconciliation Act of 1981 (OBRA). This 
legislation contained language that required states to consider the situation of 
hospitals that served a large indigent population when determining inpatient 
payment rates [5]. This legislation laid the groundwork for future DSH payments 
that were instituted by The Consolidated Omnibus Budget Reconciliation Act of 
1985 (COBRA). COBRA mandated the institution of DSH adjustments for Medicare 
payments, to supplement the losses incurred by providing large amounts of 
charitable care. This original payment supplement was initially budget neutral and 
was funded by lowering the overall IPPS rate in addition to reducing funding for 
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medical education. By 1990 DSH adjustments became a permanent part of the IPPS. 
From the end of the 1980’s through the early 90’s both forms of DSH payments 
exploded. From 1989 to 1996 Medicare DSH expenses grew from $1 billion to $4 
billion, while Medicaid’s DSH expenditure grew from $400 million in 1988 to $17.5 
billion in 1992. In response to this tremendous growth congress passed the 
Medicaid Voluntary Contribution and Provider-Specific Tax Amendments of 1991. 
This legislation placed caps on Medicaid DSH expenditure at 12% of total Medicaid 
spending [5].  
 
Present and Future 
 
 As presented earlier, to cut costs the PPACA will begin to phase out DSH and 
IME adjustments and reduce Medicare fee-for-service payments. All together, these 
cost saving measures will eliminate $316 billion in spending through the year 2022. 
These cuts will come from reductions to Medicaid and Medicare DSH payments of 
$22 billion and $34 billion respectively, and $260 billion in reduction to Medicare 
fee-for-service payments [6].  
 
Purpose of Study 
 The purpose of this study is to determine the association between DSH 
payments and relevant quality, safety, efficiency and financial health metrics. This 
information is important to the healthcare community as these metrics are used to 
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drive reimbursement and are available to the public. In addition to reimbursement 
and public reporting, a positive association between DSH payments and quality, 
safety, efficiency and financial metrics may be cause to suggest the delaying of 
further DSH reductions.  
 
Research Questions  
 
 This study answers the following research questions: 
 
1. Is DSH funding associated with measured performance in clinical outcomes 
measures? 
2. Is DSH funding associated with measured performance in hospital efficiency? 
3. Is DSH funding associated with patient safety as measured by the CMS 
scoring methodology? 
4. Is DSH funding associated with measured financial health? 
 
 
This paper used statistical analyses to identify and determine the relationship 





Review of Literature 
Socioeconomic Factors and Their Relationship to Outcomes  
 
 There have been multiple studies that have linked certain Socioeconomic 
Status (SES) factors to health outcomes. According to a report published by the 
National Quality Forum (NQF), SES represents a fundamental determinant of health. 
These SES factors determine access to and use of proper healthcare resources [7]. In 
this report the NQF acknowledges that although they have never recommended risk 
adjustments for SES, the growing evidence linking SES to health outcomes warrants 
a review of current quality measures. The report published in 2014 identifies 
different SES factors that may be used for risk adjustment such as income, 
education, race, ethnicity, and homelessness in addition to many other factors to 
consider. Not only does the report identify potential risk factors to consider, it also 
lists each factors pros, and cons. The panel convened in this report identified two-
policy concerns: 1) adequate payment to reflect higher intensity of services to 
disadvantaged populations 2) responsibility for mitigating the risks of 
sociodemographic factors. In addition to identifying policy concerns, the report 
made several recommendations for improvement in risk adjustment. The 
recommendations that are relevant for the scope of this paper include: 1) where 
there is conceptual and empirical evidence between sociodemographic factors and 
outcomes that are reflected in a performance measure those factors should be 
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included in risk adjustment of the performance score 2) establishment of a new NQF 
committee focused on disparities 3) the same guidelines for selecting clinical risk 
factors be applied to sociodemographic factors 4) NQF and other relevant agencies 
should develop a standard set of sociodemographic variables should be made 
available for performance measurement and identification of disparities. Although 
this report made several recommendations for payment and policy changes, it did 
not recommend specific performance measures; adjustment for determining 
payment; use of particular risk adjustment or statistical procedures; structuring 
performance reward/ penalty programs.  
 
 Helton et. al. (2012) performed a cross-sectional assessment of the publicly 
available CMS Hospital Compare database over data from 2006-2009. Their study 
found a negative association between Medicaid revenue and quality scores. This 
further supports the evidence linking SES to clinical outcomes, as Medicaid often 
used a proxy for lower SES. In their study, researchers noted that in addition to 
lower performance scores, facilities that serve large portions of indigent 
populations tended to decrease the quantity and quality of services provided [2].  
 
 In a study similar to the scope of this paper Dr. Allison Marier studied the 
effect of DSH funding on patient experience scores.  This study used publicly 
available impact files available from CMS as well as data from the Hospital 
Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. To 
measure the effect of supplemental DSH payments the author analyzed data from 
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providers who were slightly above and below the 15% disproportionate patient 
percentage (DPP) needed to qualify for DSH funds. The reason behind focusing on 
these particular providers was that their patient populations would in theory be 
similar, which would allow for analysis of the impact of DSH funds on their patient 
experience scores. The researcher’s results showed a significant difference of in- 
patient experience scores between those just above and just below the 15% DPP cut 
off. On average the HCAHPS score of those hospitals who qualified for DSH funding 
were 6% higher, and an even greater improvement of 6.5% was observed when 
analyzing solely non-profit providers [9]. The results of the authors study further 
reinforce the need to analyze the effect of DSH funding on providers. This paper 
employs similar statistical analysis, but analyzes the effect of DSH funding on 
performance measures of quality, safety, efficiency and financial health.  
 
Quality, Safety and Efficiency Metrics 
 
 
 A review of pertinent literature found no arguments challenging the validity 
of the Medicare Spending Per Beneficiary (MSPB) efficiency metric. The MSPB 
metric as defined by CMS measures efficiency as the average amount of Medicare 
part A and B spending per patient from 3 days before to 30 days after admission 
[13]. Medicare has targeted efficiency in the past as a means to cut costs. In the early 
1980’s Medicare began paying hospitals a fixed amount for each admission. This 
payment strategy led to a decrease in the average hospital length of stay by half. 
Christopher Chen and Dr. Clay Ackerly noted in their article published in The 
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Journal of the American Medical Association, that the introduction of the MSPB 
represents the first pay-for-efficiency measure associated with Medicare 
reimbursement [12]. To be more specific the MSPB efficiency metric accounts for 
20% of a hospitals TPS [13].   
 
 A composite mortality rate comprised of five 30-day mortality measures will 
be used as a measure of clinical outcomes in this study. This mortality composite 
includes the Acute Myocardial Infarction (AMI) 30-day mortality rate, Chronic 
Obstructive Pulmonary Disease (COPD) 30-day mortality rate, Heart Failure 30-day 
mortality rate, Pneumonia 30-day mortality rate, and the Stroke 30-day mortality 
rate. These mortality rates as defined by CMS, are calculated as the expected deaths 
divided by observed deaths for each listed condition within a 30-day window [14]. 
Relevant literature has found that the AMI 30-day mortality rate has been proven to 
be a valid and reproducible indicator of AMI care; furthermore, this measure is also 
endorsed by the National Quality forum (NQF) [14,15]. In addition to the AMI-30 
day mortality rate, the NQF has also endorsed the Pneumonia 30-day mortality rate 
as a measure of clinical outcomes [16,17]. No other relevant literature at the time of 
the study was found to refute or endorse the COPD, Heart Failure or Stroke 30-day 
mortality rates.  
 
 The final variable this study will measure will be PSI-90. PSI-90 is a 
composite of 8 patient safety indicators, with each indicator carrying a different 
weight. Patient Safety Indicators provide information on potential hospital 
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complications and adverse effects. These indicators were developed by the Agency 
for Healthcare Research and Quality (AHRQ) in conjunction with a clinician panel 
[18]. This study does not seek to determine the validity and reliability of these 
metrics, but will use these measures as a proxy for patient safety. Relevant literature 
published by The Journal of the American Medical Association has brought into 
question the validity of PSI-90, and the effect that surveillance bias has on its 
reporting [10].  
 
Financial Performance and Quality 
 
 
Relevant studies concerning financial performance and quality of care were 
consulted. Overall, the results from these studies indicate a positive correlation 
between better quality of care and increased profitability. 
 
Mitton et. al. (2006) examined the relationship between the quality and cost 
of healthcare. Their results showed that integrated health systems can achieve 
higher quality care while lowering costs simultaneously. Additionally, their results 
showed that states with higher Medicare spending had lower quality care [22]. 
These findings may be correlated to a more elderly patient mix and may be a topic 
for further investigation. 
 
A study conducted by Patricia Born and Carl Simon focused on the 
relationship between profits and quality for HMO plans. Their research examined 
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the association of the percentage of patients who received preventative measures, 
HMO profitability and HMO for-profit and not-for-profit status. Their results showed 
that patients enrolled in a not-for-profit HMO, received on average more preventive 
measures than their for-profit cohort. Furthermore, patients enrolled in higher 
profiting HMO’s received more preventative measures than those enrolled in the 
low profit HMO group [23]. These results indicate that higher quality care can be 
linked to better financial performance. 
 
Two peer-reviewed studies consulted examined the relationship between 
quality of care and financial performance in nursing homes. Chisholm et. al. (2013) 
examined the relationship between resident racial composition, quality and 
financial performance. Their results showed that nursing homes with higher 
proportions of African American residents had lower quality process measures than 
nursing homes with lower proportions or no African American residents. 
Furthermore, their research showed that nursing homes with high proportions of 
African American residents had a higher Medicaid payer mix and performed worse 
financially when compared to nursing homes with lower or no African American 
residents [24]. These results may be associated with the fact that Medicaid patients 
provide less revenue and may have more comorbidities than patients who fail to 
qualify for Medicaid. In a similar study which examined the association between 
financial performance and quality of care in nursing homes, Weech-Maldonado et. 
al. (2003) found that higher outcome measures and process of care scores were 
associated with increased financial performance [25]. These results indicate that 
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producing a higher quality service may allow the ability to achieve higher revenues 
and decrease costs. 
 
Jason Richter and David Muhlestein investigated the association between 
patient experience scores and facility profitability. Their research found that 
increased net income was associated with more positive patient satisfaction scores 
and that a 1% increase in the number of patients who would recommend the 
hospital to others was associated with over $1 million in expected net patient 
revenues. Conversely, their research indicated an even stronger association 
between negative patient experience scores and decreased net income [26]. 
Although they did not associate increased financial performance with process of 
care scores or outcomes, their results are important as patient experience scores are 
















Research Design and Methodology  
 
 The study uses a cross sectional research design in which subjects are 
observed at a specific point in time. This study used databases from CMS and 
Hospital Compare that are available to the public. These databases do not contain 
any patient specific information, and contain only provider specific information. 
This study did not require IRB approval since it does not involve human subjects. 
The data collected for this study is readily available at no cost from the Center for 
Medicare and Medicaid Services, and Hospital Compare websites. Specifically, this 
study used the Inpatient Prospective Payment System (IPPS) impact file for the 
2015 fiscal year, the Hospital Cost Report Information System (HCRIS), in 
conjunction with data readily available from the Hospital Compare database. The 
IPPS impact file data is derived from a combination of Medicare cost reports and 
Medicare claims data. The hospital compare database is based on Medicare claims 
data [19, 20, 21].  
 
Data Sample Characteristics 
 
  
The data set used for this study includes 3476 hospitals, 3384 of which are 
acute care facilities. In addition to the quality, safety, efficiency and financial metrics 
described in this study, this data set includes information on type of ownership, and 
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region in which these facilities reside. These figures are further described in the 










Government 590 17% 19 7% 
Non-Profit 2027 58% 181 71% 
Other 90 3% 0 0% 
Proprietary 769 22% 55 22% 
Grand Total 3476 100% 255 100% 








Central East 832 24% 75 29% 
Central West 831 24% 45 18% 
East Coast 1111 32% 103 40% 
Mountain 238 7% 20 8% 
Pacific 412 12% 12 5% 
Puerto Rico 52 1% 0 0% 
Grand Total 3476 100% 255 100% 
Table 2 – Facility Location 
 
 
Inclusion and exclusion criteria 
 
To analyze the association between DSH payments and the chosen metrics, 
this study will need specific inclusion and exclusion criteria. To control for the effect 
of increasing DSH payments this study will eliminate hospitals with more than 
17.5% DPP and hospitals with less than 12.5% DPP. This exclusion criterion will 
allow this study to control for other confounding factors such as extremely high and 
low DPP. Furthermore, this criterion will allow for the examination of the effects of 
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simply qualifying for DSH funds, and if qualification is associated with increased 
quality, safety, efficiency and financial health.   
 
Study Sample Construction and Size 
 
 The final sample used for analysis was constructed using information from 
the 2015 IPPS impact file, Hospital Compare data and the Healthcare Cost Report 
Information System. First, all facilities with a DPP greater than 17.5% and lower 
than 12.5% were eliminated from the data set gathered from the IPPS impact file for 
the 2015 FY. This data was then combined with metrics derived from the Hospital 
Compare database, and HCRIS data files. All facilities with insufficient or missing 
data were eliminated, leaving a final sample size of n=255 for analysis. The 
ownership and regions of the study sample, detailed in Table 1 and Table 2, 
indicate that the study sample and overall population are similar in both ownership 
and region. 160 of the 255 facilities studied qualified for DSH funding.  All facilities 
used for this study are defined as acute care facilities.  
 
Variables of Interest  
This study seeks to determine the association between DPP and hospital 
quality, safety, efficiency and financial health. To analyze these associations this 




Disproportionate Patient Percentage 
 Disproportionate Patient Percentage (DPP) will be used as a proxy variable 
for the percentage of indigent population that a hospital treats. This value is 
calculated as the Medicare Social Security Income Days divided by Total Medicare 
Days, plus Medicaid, Non Medicare Days divided by Total Patient Days and is further 
illustrated in Figure 1 below. CMS uses this variable to calculate the amount of DSH 
payment that a hospital receives. A hospital must reach 15% DPP to qualify for DSH 
payments. DPP is a continuous variable that did not need to be recoded for this 
study [9].  
 
 
Figure 1 – Disproportionate Patient Population Formula   
 
Quality of Care 
 Quality of care will be measured using five 30- day mortality measures. 
These mortality measures are tracked by the hospital compare database and are 
calculated by dividing the observed deaths within a 30-day window by the risk-
adjusted expected deaths. This produces a continuous variable that does not require 
recoding. The mortality measures that will be used in this study will include: the 30-
day Acute Myocardial Infarction (AMI), 30-day Chronic Obstructive Pulmonary 
Disease (COPD), 30-day Heart Failure, 30-day pneumonia, and 30-day Stroke 
mortality rate. These metrics were combined into one global quality of care score. A 





 To evaluate hospital efficiency, this study will use a hospitals Medicare 
Spending Per Beneficiary (MSPB). This metric is determined by evaluating hospitals 
Medicare Part A and Part B spending from 3 days’ prior to admission to 30 days 
after admission. This value is compared to the median MSPB amount from all 
hospitals and is weighted by episode count to produce a continuous efficiency 
metric. The metric is standardized so that a value of 1.0 indicates typical efficiency.  
Values higher than 1.0 indicate that a hospital may be less efficient than the typical 
(median) hospital [13].   
Patient Safety 
 Patient safety will be evaluated using patient safety indicator 90 (PSI-90). 
PSI-90 (illustrated in Table 3) is a composite rate composed of eight patient safety 
indicators, each with their own relative weight. PSIs are a measure of adverse, 
preventable events that take place within an episode of care. These rates are 
calculated using the ninth revision of the International Classification of Diseases 
Clinical Modification (ICD-9 CM) to measure potentially preventable adverse events. 
PSI-90 is the weighted average of reliability-adjusted observed to expected ratios of 
the patient safety indicators listed below. A lower score indicates fewer potential 
medical errors and adverse events. PSI-90 is a ratio that does not need recoding for 
this study [10, 18].  
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 Financial health was measured using metrics derived from the Healthcare 
Cost Report Information System (HCRIS). The metrics chosen for analysis were 
operating margin, day’s cash on hand and days in accounts receivable. These 


















 The analysis for this study included descriptive statistics and a Mann-
Whitney U test. A Mann-Whitney U test was selected due to the nonparametric 
distribution of the study sample. The tools chosen to perform the analysis include 
IBM SPSS version 23 and Microsoft Excel. Quality, efficiency, safety and financial 
metrics were grouped and analyzed depending on their facilities DPP. Groups were 
defined according to whether they surpassed or failed to meet the 15% DPP 


























 Simply put, the results of the study (displayed in Table 4) found no 
statistically significant association (Mann Whitney U (P<.05)) between DSH status 
and hospital quality, safety, efficiency or financial health. When comparing selected 
metrics between DSH and non-DSH groups, DSH groups performed nominally better 
in all areas. The most improvement seen in financial measures with operating 
margin (Mann Whitney U (P=.1660)) and days cash on hand (Mann Whitney U 
(P=.143)). These results are displayed in Figure 7 and Figure 8. Again, these 
improvements are incremental and analysis indicates that qualifying for DSH 
funding is not associated with statistically significant improvement in quality, safety, 








Figure 2 – Global Quality of Care Score 
 




Figure 5 – Patient Safety Indicator - 90 
 





Figure 7 – Days Cash On Hand 
 
 





Table 4 – Mann Whitney U Test 
 









Discussion and Conclusions  
 
 
The aim of this study was to determine the relationship between DSH 
funding and hospital quality, safety, efficiency and financial health. The results, 




This cross sectional study of the association between DSH funding and 
hospital quality, safety, efficiency and financial health used publicly available data, 
which can be easily accessed from The Center of Medicare and Medicaid Services 
and Hospital Compare databases. The results of this study were very surprising. The 
analysis demonstrated that there was no statistically significant association 
between DSH funding and hospital quality, safety, efficiency and only a nominal 
association between DSH status and financial health. These results are confounding 
for several reasons; first and foremost, one would assume that if a facility received 
increased payments for the services they provided, that they would in turn perform 
better on selected quality, efficiency, safety and financial health metrics when 
compared to facilities with similar demographics, who did not receive DSH funding. 
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Additionally, a similar study which analyzed the association between DSH funding 
and HCAHPS patient experience scores found a 6% increase in patient experience 
scores for those facilities who just qualified for DSH funding when compared to 
those who barely missed the threshold. This study expected to find similar results, 
but the increase in patient experience scores may not be associated with a 
significant change in the metrics analyzed in this study.   
 
 The results of this study suggests that the elimination of DSH funding, which 
is scheduled to be phased out in the near future would not cause a significant 
detriment to the health outcomes of the populations that are served by DSH 
facilities. This does not imply that the elimination of DSH funding would not affect 
the financial viability of the facilities that receive these supplemental payments. 
Elimination of DSH funding without provisions to ensure that providers are able to 
remain fiscally sound, could affect the communities in which they reside. These 
facilities may be the sole sources of care for their communities and the implications 




- DSH status is not associated with a statistically significant improvement 
in hospital quality, safety or efficiency. 
- Facilities that qualified for DSH funds saw nominal improvements over 
the non-DSH cohort in operating margin, day’s cash on hand and days in 





Study Limitations  
 
This study is limited by several factors that are beyond its scope. This paper 
does not take into account patient demographics beyond their Medicaid and 
Medicare classification or other factors that may affect the metrics studied. The level 
of staffing, quality of physicians and facilities, use of best practices and payer mix 




 Future researchers may expand the scope of this study in many directions. 
Area’s to explore could include the association between DSH status and the level of 
staffing and amount of expenses allocated towards salaries. Additionally, there may 
be a need to investigate the DPP formula used by CMS to determine if a facility will 
qualify for DSH status. Does this formula provide an accurate description of the 
population that a facility serves? And is there is a need to develop a new measure 
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